Patients who are beyond treatment under the standards of conventional medicine often seek help from alternative medical treatments; however, these methods pose not only medical risks for patients, but also legal risks for doctors.
A surgeon with qualifications in vascular, heart and thorax surgery treated seriously ill patients using an innovative method. The patients suffered from morbus Parkinson, multiple sclerosis, various forms of myatrophy and paralysis, traumatic spinal cord injuries, macular degenerations or psychiatric impairments such as autism. All of the patients were beyond treatment under the standards of conventional medicine. The surgeon treated them with stem cell therapy.
First-instance and appeal decisions
In April 2014 the Viennese Administrative Authority fined the surgeon under Section 49(1) of the Act on the Medical Profession for failing to observe patient welfare namely, for not evaluating the side effects and counterindications of using stem cell therapy to treat the abovementioned conditions.
In July 2015 the Viennese Administrative Tribunal(1) partly confirmed this decision. The tribunal ruled that potential health risks cannot be withheld from patients.
Supreme Administrative Court decision
On appeal, the Supreme Administrative Court(2) overruled the Viennese Administrative Tribunal's decision. The court held that the administrative tribunal had accused the surgeon of regularly using autologous stem cell therapy as a new treatment, even though clinical studies had yet to determine its benefits and risks.
According to the court, stem cells fall within the definition of medicinal products under Section 1 of the Medicinal Products Act.(3) The court could therefore revert to the doctrine and precedents on the off-label use of medicinal products. In its view, the tribunal had not shown that the treatment was clearly prohibited. Further, without a prohibition on the off-label use of medicinal products with marketing authorisation, such a prohibition cannot be based on the Medicinal Products Act. Therefore, an infringement of "compliance with existing rules according to sec 49 (1) Act on the Medical Profession" was not obvious.
The use of medicinal products or treatments that have not been clinically evaluated in terms of benefit-risk ratio for certain (new) indications is referred to as 'compassionate use'. The Declaration of Helsinki on ethical principles for medical research involving human subjects states as follows:
Unproven interventions in clinical practice
37. In the treatment of an individual patient, where proven interventions do not exist or other known interventions have been ineffective, the physician, after seeking expert advice, with informed consent from the patient or a legally authorised representative, may use an unproven intervention if in the physician's judgement it offers hope of saving life, re-establishing health or alleviating suffering. This intervention should subsequently be made the object of research, designed to evaluate its safety and efficacy. In all cases, new information must be recorded and, where appropriate, made publicly available.
According to legal literature, compassionate use is a deviation from medical standards in special treatment situations, either because the standard is unhelpful or no standard for the special treatment is available. Unlike clinical studies, it refers to individual cases and not to a clinical sample.
Under Section 49(1) of the Medical Profession Act physicians must observe the rules of medical science; however, these rules are only guidelines with respect to patient welfare insofar as it is possible to go beyond conventional medicine. Therefore, Section 49(1) does not prohibit compassionate use for patients who are beyond therapy under conventional medicine if they are comprehensively informed and the compassionate use makes objective sense.(4)
There is no legal definition of 'compassionate use' and no Supreme Court precedents in this regard. On 13 February 1956 the German Federal Court ruled(5) that a method of treatment is a clinical study and not a compassionate use if the method is applied not primarily in the interests of treating a patient, but in the interest of scientific research. A new method of treatment may be applied if the responsible medical evaluation and comparison of the expected benefits and risks of the new method with the standard treatment under consideration justify its application.(6)
New methods may be used only on patients who are fully informed that said methods imply unknown risks. Further, patients must be able to evaluate and consent to (or not) said risks.(7)
In the case at hand, all of the surgeon's patients were beyond treatment such that, according to the medical standard, no successful cure could be expected at the time of the treatment.
The Viennese Administrative Tribunal failed to establish that the applied treatment had posed a danger to the patients; rather, it stated only that health risks cannot be excluded without clinical studies. The tribunal reproached the applicant for integrating the method of treatment into regular clinical operations. Compassionate use that is legitimate in individual cases becomes illegitimate if it is adopted in regular clinical operations, as it becomes a regular treatment with an unverified method. This further implies that the person administering the treatment has applied it in multiple cases. It is unclear whether the application of a new therapy on a larger number of patients excludes the qualification of the treatment as compassionate use.
Insofar as the Viennese Administrative Tribunal questioned the surgeon's claim to have evaluated the risks of stem cell therapy in each case, the tribunal lacked evidence to evaluate the types of risk that would prohibit compassionate use. Further, the tribunal failed to establish the circumstances and specific patient information that would prohibit compassionate use. Therefore, the Supreme Administrative Court set aside the Viennese Administrative Tribunal's decision.
The Supreme Administrative Court's decision appears to favour a liberal approach to new therapies and compassionate use and enhances the possibilities for developing new therapies and alternative medicines in future. However, patient welfare remains paramount for qualifying a new method as compassionate use.
(2) 24 April 2019, RA 2015/11/0113.
(3) Kopecky, Stammzellenforschung in sterreich, 2008, 269.
(4) Resch and Wallner, Handbuch Medizinrecht (second edition), 2015, 222.
(5) III ZR 175/54.
(6) German Federal Court of Justice, 13 June 2006, VI ZR 323/04.
(7) German Federal Court of Justice, 13 June 2006, VI ZR 323/04 and Federal Court of Justice, 27 March 2007, VI ZR 55/05.
This article was first published by the International Law Office, a premium online legal update service for major companies and law firms worldwide.Register for a free subscription.
- Leading Alternative Healing Director of Total Health Institute Reviews and Receives 3rd Fellowship in Stem Cell Therapy - GlobeNewswire - November 15th, 2019
- NIST researchers use artificial intelligence for quality control of stem cell-derived tissues - National Institutes of Health - November 15th, 2019
- Modeling the early development of a primate embryo - Science Magazine - November 15th, 2019
- BREAKTHROUGH: Her vision was getting worse, then animal research made things clear - Speaking of Research - November 15th, 2019
- Stem Cell Therapy Market To Increase Exponentially During 2018 2025 - Downey Magazine - November 15th, 2019
- Stem Cell Transplants Used to Grow Fully Functional Lungs in Mice - Technology Networks - November 11th, 2019
- Human Heart Cells Transform in Space; Return to Normal on Earth: Study - The Weather Channel - November 11th, 2019
- Serving those who serve us - The Hub at Johns Hopkins - November 11th, 2019
- Kadimastem to Present Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS at the 7th International Stem Cell Meeting, in Tel-Aviv,... - November 11th, 2019
- The Value and Versatility of Clinical Flow Cytometry - Technology Networks - November 11th, 2019
- Global Cell Harvesting Industry Research: Key Companies Profile with Sales, Revenue, Market Share, Price and Competitive Situation Analysis - Inquiry... - November 11th, 2019
- Human heart cells are altered by spaceflight, but return mostly to normal on Earth - Space Daily - November 9th, 2019
- Jennifer OConnell: President Kanye in 2024? Be very afraid America - The Irish Times - November 9th, 2019
- Cord Blood Stem Cells Market Executive Summary, Introduction, Sizing, Analysis and Forecast To 2025 - Markets Gazette 24 - November 9th, 2019
- Global Animal Stem Cell Therapy Market - Industry Outlook and Forecast 2019-2024 - Real Viewpoint - November 9th, 2019
- Novel Molecule Reduces the Aggressiveness of Pediatric Cancer - Technology Networks - November 7th, 2019
- 2019s Allen Distinguished Investigators will focus on the mysteries of our cells - Yahoo Tech - November 7th, 2019
- At the American Academy of Stem Cell Physicians Live Congress 2019, FDA Safety Panel Says No to the Bad Actors - PRNewswire - November 7th, 2019
- MD Anderson Partners with Takeda to Develop CAR Natural Killer-Cell Therapy - Cancer Network - November 7th, 2019
- First UK patient treated with tissue engineered product for rare eye disease - Hospital Healthcare Europe - November 7th, 2019
- Spaceflight alters heart cells but they quickly recover back on Earth - New Scientist News - November 7th, 2019
- Stem Cell Assay Market To Witness Increase In Revenues By 2024 - Montana Ledger - November 7th, 2019
- Researchers Find Link Between Eye Disease And Degeneration Of The Brain - BioSpace - November 7th, 2019
- Physicians' Education Resource to Host Satellite Symposia at Annual American Society of Hematology Meeting and Exposition in Orlando - Business Wire - November 7th, 2019
- Keep Bioethics out of Elementary and High Schools - National Review - November 7th, 2019
- Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2025 - Virtualnewsusa - November 7th, 2019
- The Bold and the Beautiful Star Don Diamont Supports ALS Research - Soap Hub - November 7th, 2019
- International Conference on Stem Cells and Regenerative Medicine - Hoover Sun - November 5th, 2019
- Global Cancer Stem Cell Market Forecast to 2024 by Types, Application and by Regions - Exchange 99 - November 5th, 2019
- Lymphatic System Discovered To Play Key Role in Hair Regeneration - Technology Networks - November 5th, 2019
- Stem cell transplants approved for people with MS in Scotland - MS Trust - November 5th, 2019
- Johns Hopkins professor to lecture on interplay of secular bioethics, religion as part of Honors Colloquium - URI Today - November 5th, 2019
- Russell Brand Defends Lewis Hamiltons Vegan Hypocrisy and It Will Make You Think - LIVEKINDLY - November 5th, 2019
- Latest Report on Stem Cell Banking Market to Drive Amazing Growth by 2025 | Cord Blood Registry (CBR) Systems - News Hours Today - November 5th, 2019
- Global Stem Cell Cartilage Regeneration Market 2019, Trend, CAGR Status, Growth, Analysis and Forecast to 2024 - BeetleVersion - November 5th, 2019
- The House of Lords is needed to protect democracy now more than ever - The Independent - November 3rd, 2019
- Late-Term Abortion and an Election in Virginia - Newsmax - October 31st, 2019
- AIVITA Biomedical Announces Publication Detailing Immune Mechanisms Leading to Complete Remission of Measurable Metastatic Melanoma in Patient Treated... - October 31st, 2019
- CHS teacher enjoys prepping students for life out on their own - Albuquerque Journal - October 31st, 2019
- bluebird bio Reports Third Quarter 2019 Financial Results and Highlights Operational Progress - Business Wire - October 31st, 2019
- Global Cell Culture Protein Surface Coating Market: What it got next? Find out with the latest research available at 'The Market Reports' - Market... - October 31st, 2019
- SCD, HIV Gene Therapy Efforts Get $200M from NIH, Gates Foundation - Sickle Cell Anemia News - October 31st, 2019
- Global 3D Cell Culture Markets, 2019-2025: Cancer & Stem Cell Research Displays the Potential to Grow at Over 21.9% - ResearchAndMarkets.com -... - October 26th, 2019
- UCI IN THE NEWS OCT. 25, 2019 - UCI News - October 26th, 2019
- Mini-brains may already be sentient and suffering, scientists warn - Big Think - October 26th, 2019
- UK and China scientists developing new drugs to fight Tuberculosis - University of Birmingham - October 26th, 2019
- Global Stem Cell Therapy Market Global and Regional Analysis by Top Key Market Players, Key Regions, Product Segments, and Applications 2024 - Globe... - October 24th, 2019
- Do transhumanists need their own bill of rights? - Quartz - October 22nd, 2019
- Global Wound Care Market Outlook to 2024: New Product Approvals/Launches, Emergence of Stem Cell Therapy For Wound Healing - P&T Community - October 22nd, 2019
- New study reveals why breast cancer spreads to the brain - USC News - October 22nd, 2019
- Meet the axolotl: A cannibalistic salamander that regenerates its limbs and might help us better understand human stem cell therapy -... - October 22nd, 2019
- More awareness needed on stem cell donation: expert - The Hindu - October 22nd, 2019
- Lucknow: In a first, 26-yr-old DMD patient in UP survives with stem cell therapy - ETHealthworld.com - October 22nd, 2019
- Registration Open for The Eye and The Chip Research Congress - Newswise - October 22nd, 2019
- Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services - P&T Community - October 22nd, 2019
- 'I've potentially saved a stranger's life by donating my blood stem cells and it was painless' - inews - October 22nd, 2019
- CST and Cell Press launch Cell Mentor in China - BSA bureau - October 22nd, 2019
- How stem cells are helping to mend broken hearts - Belfast Telegraph - October 22nd, 2019
- Iran sends US list of names for its proposed prisoner swap - Stars and Stripes - October 22nd, 2019
- Multiple Myeloma Experts, Patients, Advocates and Caregivers Team Up to Hike Through Patagonia - BioSpace - October 22nd, 2019
- Analysis Determines Cost Effectiveness of Various Treatment Strategies for Multiple Myeloma - Cancer Therapy Advisor - October 11th, 2019
- Stem cell therapy helped Owen Franks but there's still plenty to prove - Stuff.co.nz - October 11th, 2019
- AgeX Therapeutics to Present at Metabesity 2019 - Business Wire - October 11th, 2019
- Stem Cell Characterization Kits Market 08-Year Market Forecast and Trends Analysis Research Report - The Tribune City - October 10th, 2019
- New Cambridge research could lead to novel cancer therapies - Business Weekly - October 10th, 2019
- Global 3D Bioprinting Market Outlook, 2019-2024 - Market Anticipated to Reach $1.64 Billion by 2024 - ResearchAndMarkets.com - Business Wire - October 10th, 2019
- Stem Cell Cartilage Regeneration Market 2019: Prosperous Growth, Recent Trends and Demand by Top Key Vendors like Anika Therapeutics, Biomet,... - October 10th, 2019
- Industry Champion Jim Greenwood to Retire Following 2020 Elections - BioSpace - October 10th, 2019
- Cell Culture Protein Surface Coatings Market will Going to be Worth US$ 623.4 Mn by 2020 - Online News Guru - October 10th, 2019
- NIH funding bolsters rare diseases research collaborations | National Institutes of Health - National Institutes of Health - October 4th, 2019
- Stem Cell Therapy Market worth USD 4759.27 Million By 2024 - Global Market News 24 - October 4th, 2019
- Genome editing to be tested in kidney organoids - UW Medicine Newsroom - October 2nd, 2019
- First Patient Enrolled in Novel Stem Cell Trial for Heart Failure Treatment - Newswise - October 2nd, 2019
- Vor Biopharma Hires Senior Cell and Gene Therapy Leaders as Chief Technology Officer and Vice President of Research - Business Wire - October 2nd, 2019
- Now in development: off-the-shelf stem cells - Knowable Magazine - September 28th, 2019
- Immunity Against Cancer? Engineered Killer T Cells May Be the Key. - SciTechDaily - September 28th, 2019
- 'Provocative' Results With Stem Cells in Progressive MS - Medscape - September 27th, 2019
- 'I've Been Duped': Disabled Veteran Says He Spent Thousands at Health Center With No Improvement - NBC Bay Area - September 27th, 2019
- Finding alternatives to animal testing - University of California - September 27th, 2019
- Gene therapy shows promise repairing brain tissue damaged by stroke - National Institute on Aging - September 27th, 2019